Neurotech Pharmaceuticals
Neurotech Pharmaceuticals
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants | Macular Telangiectasia Type 2 (MacTel) | Recruiting | Phase 4 | 2026-09-25 | NCT06971939 | |
| A Study to Determine the Safety and Efficacy of NT-501 With MHFM | macular telangiectasia type 2 | Active, not recruiting | Phase 3 | 2025-07-10 | NCT06397131 |